$MRNA Moderna, Inc. Insider Trading Week 10/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Moderna, Inc. in week 10/2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 133.29 | 10,000 | 1,332,900 | 7,504,880 | 7.5 M to 7.5 M (-0.13 %) |
Mar 12 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,411,868 | 6.4 M to 6.4 M (-0.03 %) |
Mar 12 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 133.24 | 9,000 | 1,199,160 | 6,413,868 | 6.4 M to 6.4 M (-0.14 %) |
Mar 12 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 131,139 | |
Mar 12 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 133.29 | 6,600 | 879,714 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 12 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 624,822 | |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 133.24 | 5,000 | 666,200 | 0 | 5 K to 0 (-100.00 %) |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 11 2021 | MRNA | Moderna, Inc. | NABEL ELIZABETH G | Director | Option Exercise | A | 129.75 | 1,139 | 147,785 | 1,139 | |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 624,822 | |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 133.24 | 5,000 | 666,200 | 0 | 5 K to 0 (-100.00 %) |
Mar 11 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 11 2021 | MRNA | Moderna, Inc. | NABEL ELIZABETH G | Director | Option Exercise | A | 129.75 | 1,139 | 147,785 | 1,139 | |
Mar 10 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 25.93 | 6,600 | 171,138 | 137,739 | |
Mar 10 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 127.11 | 6,600 | 838,926 | 901 | 7.5 K to 901 (-87.99 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 25.93 | 6,600 | 171,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 629,822 | |
Mar 10 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 129.41 | 5,000 | 647,050 | 0 | 5 K to 0 (-100.00 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 14.22 | 5,000 | 71,100 | 40,175 | |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 1,478 | 18,046 | 0 | |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 20.93 | 10,000 | 209,300 | 180,798 | |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 132.91 | 471 | 62,601 | 0 | 471 to 0 (-100.00 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 131.83 | 2,000 | 263,660 | 471 | 2.5 K to 471 (-80.94 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 130.76 | 2,611 | 341,414 | 2,471 | 5.1 K to 2.5 K (-51.38 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 129.80 | 2,312 | 300,098 | 5,082 | 7.4 K to 5.1 K (-31.27 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 128.62 | 2,698 | 347,017 | 7,394 | 10.1 K to 7.4 K (-26.73 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 127.73 | 1,855 | 236,939 | 10,092 | 11.9 K to 10.1 K (-15.53 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 126.75 | 1,350 | 171,113 | 11,947 | 13.3 K to 11.9 K (-10.15 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 125.68 | 1,361 | 171,050 | 13,297 | 14.7 K to 13.3 K (-9.29 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 124.35 | 273 | 33,948 | 14,658 | 14.9 K to 14.7 K (-1.83 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 123.48 | 1,547 | 191,024 | 14,931 | 16.5 K to 14.9 K (-9.39 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 14.22 | 5,000 | 71,100 | 16,478 | 11.5 K to 16.5 K (+43.56 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 1,478 | 18,046 | 11,478 | 10 K to 11.5 K (+14.78 %) |
Mar 10 2021 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 20.93 | 10,000 | 209,300 | 10,000 | 0 to 10 K |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 133.50 | 100 | 13,350 | 132,568 | 132.7 K to 132.6 K (-0.08 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 132.56 | 643 | 85,236 | 132,668 | 133.3 K to 132.7 K (-0.48 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 131.35 | 1,558 | 204,643 | 133,311 | 134.9 K to 133.3 K (-1.16 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 130.43 | 2,325 | 303,250 | 134,869 | 137.2 K to 134.9 K (-1.69 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 129.22 | 1,370 | 177,031 | 137,194 | 138.6 K to 137.2 K (-0.99 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 128.46 | 1,050 | 134,883 | 138,564 | 139.6 K to 138.6 K (-0.75 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 127.40 | 900 | 114,660 | 139,614 | 140.5 K to 139.6 K (-0.64 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 125.63 | 300 | 37,689 | 140,514 | 140.8 K to 140.5 K (-0.21 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 124.37 | 500 | 62,185 | 140,814 | 141.3 K to 140.8 K (-0.35 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 123.50 | 1,500 | 185,250 | 141,314 | 142.8 K to 141.3 K (-1.05 %) |
Mar 08 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 122.10 | 800 | 97,680 | 142,814 | 143.6 K to 142.8 K (-0.56 %) |